ImmuCell Corporation

ICCC | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.41

+$0.15 (+1.46%)

Nov 2, 2026, 9:33 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-1.04M	-2.16M	-5.77M	-2.49M	-78.29K	-1.02M
Depreciation & Amortization	2.73M	2.69M	2.72M	2.49M	2.46M	2.35M
Stock-Based Compensation	295.87K	326K	368.87K	266.24K	144.31K	253.14K
Other Working Capital	-55.23K	117.41K	88.14K	180.24K	-245.49M	238.9K
Other Non-Cash Items	2.54M	-91.76K	126.44K	28.8K	18.56K	-780.35K
Deferred Income Tax	n/a	n/a	n/a	n/a	30.96K	-14.63K
Change in Working Capital	-2.05M	-406.52K	-2.11M	-1.83M	-1.62M	532.26K
Operating Cash Flow	2.48M	357.9K	-4.67M	-1.54M	954.17K	1.32M
Capital Expenditures	-1.25M	-465.73K	-1.89M	-3.98M	-2.61M	-4.07M
Cash Acquisitions	n/a	n/a	n/a	n/a	15.29K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-15.29K	-1.99M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	996K	3.45M
Other Investing Acitivies	36.13K	4.5K	2.47K	11K	15.29K	45.6K
Investing Cash Flow	-1.21M	-461.23K	-1.89M	-3.96M	-1.6M	-2.57M
Debt Repayment	-1.48M	-1.47M	1.81M	1.1M	-368.27K	1.96M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-82.51K	-5.04K	-81.53K	-19.31K	13.97K	-53.13K
Financial Cash Flow	-1.21M	2.88M	1.75M	1.11M	3.88M	1.91M
Net Cash Flow	48.6K	2.78M	-4.81M	-4.39M	3.24M	656.64K
Free Cash Flow	1.22M	-107.82K	-6.57M	-5.52M	-1.65M	-2.76M
Adj. Free Cash Flow	928.98K	-433.82K	-6.94M	-5.79M	-1.8M	-3.01M
Maintenance CapEx	n/a	n/a	-1.89M	-3.98M	n/a	-1.48M
Growth CapEx	-1.25M	-465.73K	n/a	n/a	-2.61M	-2.59M
Owner Earnings	2.48M	357.9K	-6.57M	-5.52M	954.17K	-162.85K